As an ECM remodeling enzyme, the relevance of LOX in promoting angiogenesis to reshape the TME of HCC has recently been identified by Yang et al. They demonstrated that TICs express higher levels of LOX than the corresponding control cells, and that the LOX expression level correlates positively with VEGFA and VEGFC. The gene discussed is LOX; the disease is hepatocellular carcinoma.